Chad E. Beyer

3.8k total citations
53 papers, 2.6k citations indexed

About

Chad E. Beyer is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Chad E. Beyer has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cellular and Molecular Neuroscience, 19 papers in Molecular Biology and 14 papers in Psychiatry and Mental health. Recurrent topics in Chad E. Beyer's work include Neurotransmitter Receptor Influence on Behavior (20 papers), Neuroscience and Neuropharmacology Research (13 papers) and Receptor Mechanisms and Signaling (11 papers). Chad E. Beyer is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (20 papers), Neuroscience and Neuropharmacology Research (13 papers) and Receptor Mechanisms and Signaling (11 papers). Chad E. Beyer collaborates with scholars based in United States, Canada and South Africa. Chad E. Beyer's co-authors include Jeffery D. Steketee, Lee E. Schechter, Sharon Rosenzweig‐Lipson, Robert H. Ring, Zoë A. Hughes, Brian J. Platt, Jessica E. Malberg, Meiyi Zhang, Jason M. Dwyer and Xavier Khawaja and has published in prestigious journals such as Analytical Chemistry, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Chad E. Beyer

52 papers receiving 2.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chad E. Beyer 1.2k 835 552 412 375 53 2.6k
Sharon Rosenzweig‐Lipson 1.8k 1.5× 1.2k 1.4× 523 0.9× 583 1.4× 409 1.1× 72 3.4k
Mark Prendergast 1.4k 1.2× 1.2k 1.4× 519 0.9× 259 0.6× 447 1.2× 168 3.9k
Mitsuhiko Yamada 1.7k 1.5× 1.5k 1.8× 545 1.0× 514 1.2× 339 0.9× 181 4.1k
Yutaka Gomita 1.3k 1.1× 775 0.9× 238 0.4× 215 0.5× 426 1.1× 236 2.7k
Dennis E. Schmidt 1.4k 1.2× 1.0k 1.2× 421 0.8× 252 0.6× 749 2.0× 89 3.7k
Przemysław Bieńkowski 1.5k 1.3× 842 1.0× 324 0.6× 187 0.5× 557 1.5× 177 3.2k
Eric A. Engleman 1.6k 1.4× 1.0k 1.2× 332 0.6× 171 0.4× 398 1.1× 78 2.5k
Thomas P. Blackburn 2.2k 1.9× 1.6k 1.9× 347 0.6× 339 0.8× 440 1.2× 70 3.6k
Leonard L. Howell 2.5k 2.1× 1.1k 1.4× 584 1.1× 189 0.5× 675 1.8× 131 3.8k
Claudio D’Addario 955 0.8× 1.1k 1.4× 617 1.1× 127 0.3× 372 1.0× 128 2.9k

Countries citing papers authored by Chad E. Beyer

Since Specialization
Citations

This map shows the geographic impact of Chad E. Beyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad E. Beyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad E. Beyer more than expected).

Fields of papers citing papers by Chad E. Beyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad E. Beyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad E. Beyer. The network helps show where Chad E. Beyer may publish in the future.

Co-authorship network of co-authors of Chad E. Beyer

This figure shows the co-authorship network connecting the top 25 collaborators of Chad E. Beyer. A scholar is included among the top collaborators of Chad E. Beyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad E. Beyer. Chad E. Beyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beyer, Chad E., et al.. (2024). Meta-analysis of the comparative efficacy of benzodiazepines and antidepressants for psychic versus somatic symptoms of generalized anxiety disorder. Comprehensive Psychiatry. 132. 152479–152479. 1 indexed citations
2.
Moodley, Keymanthri & Chad E. Beyer. (2019). Tygerberg Research Ubuntu-Inspired Community Engagement Model: Integrating Community Engagement into Genomic Biobanking. Biopreservation and Biobanking. 17(6). 613–624. 30 indexed citations
3.
Beyer, Chad E., et al.. (2017). Meta-analysis: Risk of dry mouth with second generation antidepressants. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 84(Pt A). 282–293. 34 indexed citations
4.
Schalkwyk, Gerrit I. van, et al.. (2017). Antipsychotics for aggression in adults: A meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 81. 452–458. 27 indexed citations
5.
Schalkwyk, Gerrit I. van, Chad E. Beyer, Andrés Martin, & Fred R. Volkmar. (2016). College students with autism spectrum disorders: A growing role for adult psychiatrists. Journal of American College Health. 64(7). 575–579. 5 indexed citations
6.
Beyer, Chad E., Ciara Staunton, & Keymanthri Moodley. (2014). The implications of Methylphenidate use by healthy medical students and doctors in South Africa. BMC Medical Ethics. 15(1). 20–20. 26 indexed citations
7.
Beyer, Chad E. & Stephen M. Stahl. (2010). Next generation antidepressants : moving beyond monoamines to discover novel treatment strategies for mood disorders. Cambridge University Press eBooks. 4 indexed citations
8.
9.
Beyer, Chad E., Jason M. Dwyer, Michael J. Piesla, et al.. (2010). Depression-like phenotype following chronic CB1 receptor antagonism. Neurobiology of Disease. 39(2). 148–155. 124 indexed citations
10.
Ring, Robert H., Lee E. Schechter, Sarah K. Leonard, et al.. (2009). Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology. 58(1). 69–77. 124 indexed citations
11.
Beyer, Chad E. & Thomas I.F.H. Cremers. (2007). Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin?. European Journal of Pharmacology. 580(3). 350–354. 43 indexed citations
12.
Beyer, Chad E. & Zoë A. Hughes. (2007). Innovations in CNS drug discovery: differentiating strategies to treat depression. Expert Opinion on Drug Discovery. 2(10). 1369–1377. 1 indexed citations
13.
Smith, Valerie A., Chad E. Beyer, & Michael R. Brandt. (2006). Neurochemical changes in the RVM associated with peripheral inflammatory pain stimuli. Brain Research. 1095(1). 65–72. 12 indexed citations
14.
Beyer, Chad E., Qian Lin, Sharon Rosenzweig‐Lipson, & Lee E. Schechter. (2006). α2A-adrenoceptors enhance the serotonergic effects of fluoxetine. European Journal of Pharmacology. 539(3). 164–167. 9 indexed citations
15.
Rosenzweig‐Lipson, Sharon, Chad E. Beyer, Zoë A. Hughes, et al.. (2006). Differentiating antidepressants of the future: Efficacy and safety. Pharmacology & Therapeutics. 113(1). 134–153. 144 indexed citations
16.
Schechter, Lee E., Robert H. Ring, Chad E. Beyer, et al.. (2005). Innovative approaches for the development of antidepressant drugs: Current and future strategies. PubMed. 2(4). 590–611. 186 indexed citations
17.
Beyer, Chad E., Afshin Ghavami, Qian Lin, et al.. (2004). Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo. Brain Research. 1022(1-2). 214–220. 27 indexed citations
18.
Beyer, Chad E., David Stafford, Mark LeSage, John R. Glowa, & Jeffery D. Steketee. (2001). Repeated exposure to inhaled toluene induces behavioral and neurochemical cross-sensitization to cocaine in rats. Psychopharmacology. 154(2). 198–204. 48 indexed citations
19.
Beyer, Chad E. & Jeffery D. Steketee. (1999). Dopamine depletion in the medial prefrontal cortex induces sensitized-like behavioral and neurochemical responses to cocaine. Brain Research. 833(2). 133–141. 61 indexed citations
20.
Beyer, Chad E., Jeffery D. Steketee, & D. Saphier. (1998). Antioxidant properties of melatonin—an emerging mystery. Biochemical Pharmacology. 56(10). 1265–1272. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon Rosenzweig‐Lipson Breakdown of academic impact, for papers by Mark Prendergast Breakdown of academic impact, for papers by Mitsuhiko Yamada Breakdown of academic impact, for papers by Yutaka Gomita Breakdown of academic impact, for papers by Dennis E. Schmidt Breakdown of academic impact, for papers by Przemysław Bieńkowski Breakdown of academic impact, for papers by Eric A. Engleman Breakdown of academic impact, for papers by Thomas P. Blackburn Breakdown of academic impact, for papers by Leonard L. Howell Breakdown of academic impact, for papers by Claudio D’Addario
Rankless by CCL
2026